# Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

> **NCT02244580** · NA · COMPLETED · sponsor: **BioNTech Diagnostics GmbH** · enrollment: 1010 (actual)

## Conditions studied

- Invasive Breast Cancer

## Interventions

- **DEVICE:** MammaTyper™

## Key facts

- **NCT ID:** NCT02244580
- **Lead sponsor:** BioNTech Diagnostics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 1010 (ACTUAL)
- **Last updated:** 2016-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244580, "Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02244580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*